We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Impax Loses Bid For Generic Version Of Rilutek

Law360 (September 1, 2004, 12:00 AM EDT) -- Impax Laboratories Inc.'s proposed generic version of Rilutek infringes on Aventis SA's patent for the brand version of the drug, a U.S. federal court has ruled.

In its decision, Judge Joseph...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.